Related Articles
-
-
Variability and Test Error with the LAL Assay
Introduction The Limulus amebocyte lysate (LAL) assay is the compendial test for the examination of bacterial endotoxin in pharmaceutical products (as described in...
-
AstraZeneca and Montreal Heart Institute to screen 80,000 samples for cardiovascular and diabetes genetic traits – Courtesy (World Pharma News)
AstraZeneca today announced a collaboration with the Montreal Heart Institute (MHI) in Quebec, Canada, to search the genomes of...
-
Analysis of Counterfeit FDA-Regulated Products at the Forensic Chemistry Center: Rapid Visual and Chemical Screening Procedures Inside and Outside of the Laboratory
Abstract Field and laboratory screening methods have been described for detecting counterfeit pharmaceutical packaging (cartons, bottles, etc) and finished...
-
Analytical Challenges and Case Studies in Method Development for Fixed-Dose Combinations
The utilization of Fixed Dose Combinations (FDC) has been increasing. This webcast will discuss various challenges and solutions as...
-
-
Stability Assessment for Shipment of API and Drug Products
Increasing requests from regulatory agencies have focused on evaluation of APIs and drug products during shipment. However, little guidance...
-
Drug Discovery and Biotechnology Trends
Pharmaceutical and biopharmaceutical firms need to reduce the cost and lead time of drug development. A range of recently...
